Polycystic kidney disease interventions: Difference between revisions
m Khurram Afzal moved page Polycystic kidney disease intervention to Polycystic kidney disease interventions |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Polycystic kidney disease}} | {{Polycystic kidney disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{MKA}} | ||
==Overview== | ==Overview== | ||
There are no recommended therapeutic interventions for the management of [disease name]. | |||
OR | |||
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3] | |||
OR | |||
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3]. | |||
OR | |||
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis. | |||
OR | |||
[Name of intervention] is the mainstay of treatment for [disease or malignancy]. | |||
==Indications== | |||
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either: | |||
*[Indication 1] | |||
*[Indication 2] | |||
*[Indication 3] | |||
OR | |||
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either: | |||
*[Indication 1] | |||
*[Indication 2] | |||
*[Indication 3] | |||
==[Name of Intervention] == | |||
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis. | |||
OR | |||
[Name of intervention] is the mainstay of treatment for [disease or malignancy]. | |||
OR | |||
The mechanism of [name of intervention] is as follows: | |||
==Contraindications== | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: (name of the system)]] |
Revision as of 18:52, 7 June 2018
Polycystic kidney disease Microchapters |
Differentiating Polycystic kidney disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polycystic kidney disease interventions On the Web |
American Roentgen Ray Society Images of Polycystic kidney disease interventions |
Risk calculators and risk factors for Polycystic kidney disease interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
There are no recommended therapeutic interventions for the management of [disease name].
OR
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
Indications
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
[Name of Intervention]
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
OR
The mechanism of [name of intervention] is as follows: